Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Jay Moon Lee, M.D.
Jay Moon Lee, M.D.

Specialty:

Thoracic Surgery/Cardiothoracic Surgery

General Information:

Gender:
Male
Language(s):
English

Affiliation(s):

Surgical Director, Thoracic Oncology Program
Assistant Professor, Department of Surgery, Cardiothoracic Surgery, Surgical Oncology, General Thoracic Surgery, Sarcoma Program
Member, JCCC Tumor Immunology Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center

Education:

Fellowship:
CardioThoracic Surgery, Brigham and Women's Hospital, 2004 - 2006
Residency:
Surgery, Duke University Medical Center, 2001 - 2004
Surgery, Georgetown University Medical Center, 1998 - 1999
Internship:
Surgery, Georgetown University Medical Center, 1997 - 1998
Medical Degree:
M.D., UCLA School of Medicine, 1997

Certification(s):

Medical Board Certification(s):
Surgery, American Board of Surgery, 2004
Surgery, American Board of Thoracic Surgery, 2009

Contact Information:

Surgery:
(310) 794-7788 Patient appointments
Thoracic Surgery:
(310) 794-7333 Patient appointments
(310) 825-9111 Medical center operator
(310) 825-6301 Medical center page operator
General Thoracic Surgery:
(310) 794-7333 Information and patient appointments
Lung Cancer Program:
(310) 794-7333 Patient appointments
Thoracic Oncology Program:
(310) 794-7333 Information and referral
(310) 206-6909 Information and referral
UCLA Sarcoma Program:
(310) 825-7086 Information and referral
Email:
Website:

Practice Information:

Clinical Interest(s):
Esophageal
Lung
Lung Cancer and Chest Malignancies
Mesothelioma
Sarcoma
Thoracic
Thoracic Cancer
Thymus
Trachea

Scientific Interest(s):

Dr. Jay Lee is interested in immunotherapy and gene therapy in lung cancer and the application of nanotechnology as a treatment and imaging modality in lung cancer.

Selected Cancer-Related Publications:

Kachroo P, Pak PS, Sandha HS, Lee C, Elashoff D, Nelson SD, Chmielowski B, Selch MT, Cameron RB, Holmes EC, Eilber FC, Lee JM. Single-institution, multidisciplinary experience with surgical resection of primary chest wall sarcomas. J Thorac Oncol. 2012 Mar;7(3):552-8.

Kachroo P, Pak PS, Sandha HS, Nelson SD, Seeger LL, Cameron RB, Eilber FC, Lee JM. Chest wall sarcomas are accurately diagnosed by image-guided core needle biopsy. J Thorac Oncol. 2012 Jan;7(1):151-6.

Lee G, Gardner BK, Elashoff DA, Purcell CM, Sandha HS, Mao JT, Krysan K, Lee JM, Dubinett SM. Elevated levels of CXC chemokine connective tissue activating peptide (CTAP)-III in lung cancer patients. Am J Transl Res. 2011 May 15;3(3):226-33.

Baratelli F, Lee JM, Hazra S, Lin Y, Walser TC, Schaue D, Pak PS, Elashoff D, Reckamp K, Zhang L, Fishbein MC, Sharma S, Dubinett SM. PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer. Am J Transl Res. 2010 Jun 30;2(4):356-67.

Baratelli F, Takedatsu H, Hazra S, Peebles K, Luo J, Kurimoto PS, Zeng G, Batra RK, Sharma S, Dubinett SM, Lee JM. Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer. J Transl Med. 2008 Jul 22;6:38.